Calsar Co Film-Coated Tablet
PDF Leaflet Revision Date: 18 March 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of essential hypertension in patients stabilized on individual components.
Dosage (summary)
One tablet daily; maximum 10/320/25 mg.
Onset of Action / Duration
Onset: 2 hours, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding.
Key Drug Interactions
- Dual blockade of RAAS
- Lithium
- NSAIDs
Contraindications
- Hypersensitivity
- Severe renal impairment
- Severe hepatic impairment
- Pregnancy
- Breastfeeding
Common side effects
- Dizziness
- Hypotension
- Fatigue
- Hypokalaemia
Counselling Points
- Monitor blood pressure regularly
- Avoid potassium supplements
- Report any skin changes
Serious warnings
- Angioedema
- Risk of hypotension
- Non-melanoma skin cancer
Important Disclaimer
The Calsar Co Film-Coated Tablet professional information leaflet below is the property of Pharma Dynamics and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
